A

Assertio Holdings
D

ASRT

0.63520
USD
-0.03
(-4.12%)
مغلق
حجم التداول
6,175
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
60,839,927
أصول ذات صلة
B
BHC
-0.01500
(-0.24%)
6.17000 USD
E
EOLS
-0.02500
(-0.27%)
9.27000 USD
I
IPHA
0.01000
(0.55%)
1.83000 USD
M
MNKD
-0.04500
(-1.18%)
3.76000 USD
S
SNDL
-0.01500
(-1.19%)
1.25000 USD
S
SWTX
0.175
(0.37%)
46.965 USD
TEVA
TEVA
-0.095
(-0.56%)
16.970 USD
V
VSTM
-0.24000
(-4.63%)
4.94500 USD
V
VTVT
0.870
(5.70%)
16.130 USD
المزيد
الأخبار المقالات

العنوان: Assertio Holdings

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild tomoderate pain.